Ocugen, Inc. Files 8-K Report
Ticker: OCGN · Form: 8-K · Filed: Aug 13, 2024 · CIK: 1372299
| Field | Detail |
|---|---|
| Company | Ocugen, INC. (OCGN) |
| Form Type | 8-K |
| Filed Date | Aug 13, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: OCGN
TL;DR
OCGN filed an 8-K on Aug 13th - something important happened, check the details.
AI Summary
On August 13, 2024, Ocugen, Inc. filed an 8-K report, indicating a significant corporate event. The filing does not detail specific financial transactions or strategic moves but serves as a notification of a material event to the SEC and investors. The company's common stock trades on The Nasdaq Stock Market LLC under the ticker OCGN.
Why It Matters
This 8-K filing signals a material event for Ocugen, Inc., requiring immediate disclosure to the public and potentially impacting investor decisions regarding the OCGN stock.
Risk Assessment
Risk Level: medium — 8-K filings can cover a wide range of events, some positive and some negative, making the immediate risk level uncertain without further details.
Key Players & Entities
- Ocugen, Inc. (company) — Registrant
- August 13, 2024 (date) — Date of Earliest Event Reported
- OCGN (company) — Trading Symbol
- The Nasdaq Stock Market LLC (company) — Exchange
FAQ
What is the specific event being reported in this 8-K filing?
The provided text is the cover page of the 8-K filing and does not specify the exact event being reported. It only states the date of the earliest event reported as August 13, 2024.
What is Ocugen, Inc.'s stock ticker symbol and where is it traded?
Ocugen, Inc.'s common stock trades under the symbol OCGN on The Nasdaq Stock Market LLC.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on August 13, 2024.
What is Ocugen, Inc.'s principal executive office address?
Ocugen, Inc.'s principal executive office is located at 11 Great Valley Parkway, Malvern, Pennsylvania 19355.
Is Ocugen, Inc. an emerging growth company?
The filing includes a checkbox for 'Emerging growth company' but does not indicate whether Ocugen, Inc. has elected to be classified as one.
Filing Stats: 439 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2024-08-13 08:00:42
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value per share OCGN The Nasdaq
Filing Documents
- tm2421524d1_8k.htm (8-K) — 25KB
- tm2421524d1_ex99-1.htm (EX-99.1) — 29KB
- tm2421524d1_ex99-1img001.jpg (GRAPHIC) — 469KB
- tm2421524d1_ex99-1img002.jpg (GRAPHIC) — 407KB
- tm2421524d1_ex99-1img003.jpg (GRAPHIC) — 679KB
- tm2421524d1_ex99-1img004.jpg (GRAPHIC) — 318KB
- tm2421524d1_ex99-1img005.jpg (GRAPHIC) — 238KB
- tm2421524d1_ex99-1img006.jpg (GRAPHIC) — 407KB
- tm2421524d1_ex99-1img007.jpg (GRAPHIC) — 626KB
- tm2421524d1_ex99-1img008.jpg (GRAPHIC) — 458KB
- tm2421524d1_ex99-1img009.jpg (GRAPHIC) — 425KB
- tm2421524d1_ex99-1img010.jpg (GRAPHIC) — 316KB
- tm2421524d1_ex99-1img011.jpg (GRAPHIC) — 256KB
- tm2421524d1_ex99-1img012.jpg (GRAPHIC) — 249KB
- tm2421524d1_ex99-1img013.jpg (GRAPHIC) — 466KB
- tm2421524d1_ex99-1img014.jpg (GRAPHIC) — 452KB
- tm2421524d1_ex99-1img015.jpg (GRAPHIC) — 473KB
- tm2421524d1_ex99-1img016.jpg (GRAPHIC) — 168KB
- tm2421524d1_ex99-1img017.jpg (GRAPHIC) — 465KB
- tm2421524d1_ex99-1img018.jpg (GRAPHIC) — 217KB
- tm2421524d1_ex99-1img019.jpg (GRAPHIC) — 399KB
- tm2421524d1_ex99-1img020.jpg (GRAPHIC) — 169KB
- tm2421524d1_ex99-1img021.jpg (GRAPHIC) — 396KB
- 0001104659-24-088678.txt ( ) — 11260KB
- ocgn-20240813.xsd (EX-101.SCH) — 3KB
- ocgn-20240813_lab.xml (EX-101.LAB) — 33KB
- ocgn-20240813_pre.xml (EX-101.PRE) — 22KB
- tm2421524d1_8k_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. Attached as Exhibit 99.1 hereto and incorporated herein by reference is a presentation that Ocugen, Inc. will post on its website on August 13, 2024 and may use from time to time in presentations or discussions with investors, analysts, and other parties.
Financial Statements and Exhibits
Financial Statements and Exhibits. The following exhibits are being filed herewith: (d) Exhibits Exhibit No. Document 99.1 Ocugen, Inc. Presentation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 13, 2024 OCUGEN, INC. By: /s/ Shankar Musunuri Name: Shankar Musunuri Title: Chairman, Chief Executive Officer, & Co-Founder